Wisconsin Alumni Research Foundation
A Leader in University Technology Transfer since 1925
Home | Printer Friendly
Technologies
New Inventions
New Patents
Agriculture (144)
Analytical Instrumentation (129)
Cleantech (89)
Diagnostic Assays (61)
Drug Discovery (164)
Disease models
Drug delivery
Drug production & design
Gene therapy
Libraries
Pre-clinical testing
Stem cells
Targets
Education & Training (9)
Engineering (12)
Engines & Power Electronics (54)
Food & Supplements (56)
Information Technology (120)
Materials & Chemicals (94)
Medical Devices (76)
Medical Imaging (125)
Micro & Nanotech (69)
Miscellaneous (2)
Pharmaceuticals & Vitamin D (209)
Plasma Processing (25)
Pluripotent Cells (23)
Radiation Therapy (38)
Research Tools (287)
Semiconductors & Integrated Circuits (55)
Veterinary (20)
WARF: P04277US Drug Discovery
In Vitro Differentiation of Neural Stem Cells and Neurons from Human Embryonic Stem Cells
INVENTORS Su-Chun Zhang, Xue-jun Li
OVERVIEW
This invention provides a simple and efficient method of differentiating human embryonic stem cells into neural stem cells and neurons for pharmaceutical screening and potential transplant therapy. The system is easily standardized and completely chemically defined. First, human ES cells are aggregated and treated with fibroblast growth factors to induce the cells’ development into early neural stem cells. Different combinations of growth factors are then used to direct these naïve neural stem cells to become progenitors of various types of neurons. The neural progenitors organize into neural tube-like rosettes that can be readily enriched and further differentiated into functional spinal motor neurons, midbrain dopaminergic neurons, or forebrain dopaminergic neurons.
KEY BENEFITS
  • Allows directed differentiation of human ES cells toward a specialized neuronal fate in a standard culture system
  • Can be used to isolate a population of forebrain dopamine neurons, midbrain dopamine neurons, or spinal motor neurons at specific developmental stages
  • Useful for pharmaceutical and toxicological screening of a compound’s effect on neuronal development and function
ADDITIONAL INFORMATION
Intellectual Property Status
Tech Fields
Drug Discovery - Stem cells
Drug Discovery - Pre-clinical testing
Pluripotent Cells - Differentiation
CONTACT INFORMATION
For current licensing status, please contact our team at licensing@warf.org or phone 608.262.4924. (Clicking this link will open a contact form in a popup window. If you have problems viewing the form, try disabling your popup blocker software.)
WARF Medal of Technology Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.


Contact Us | WARF Extranet | Privacy Policy | IMS Powered